eISSN: 2720-5371
ISSN: 1230-2813
Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
3/2023
vol. 32
 
Poleć ten artykuł:
Udostępnij:
Artykuł przeglądowy

The COVID-19 pandemic: new challenges for the mental health protection system

Viacheslav Mishyiev
1
,
Borys Mykhaylov
1
,
Eugenia Grinevich
1
,
Vitaliy Omelyanovich
1
,
Abbas Kaafarani
2

  1. Department of General, Children’s, Forensic Psychiatry, and Narcology, Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine
  2. Kharkov Medical Academy of Postgraduate Education, Kharkov, Ukraine
Adv Psychiatry Neurol 2023; 32 (3): 138–146
Data publikacji online: 2023/10/18
Plik artykułu:
- PPN-00270.pdf  [0.16 MB]
Pobierz cytowanie
 
Metryki PlumX:
 

INTRODUCTION

The increase in the number of extreme situations, including Russia’s invasion of Ukraine and the COVID-19 pandemic, dictates the need for medical treatment measures and the medical-psychological rehabilitation of persons who have suffered because of the negative impact of emotional stressors.

A significant proportion of the population of Ukraine has a mental disorder. This determines the need for the operative assessment of patients’ condition, prognosis of the detected disorders, and implementation of possible treatment and medical rehabilitation measures.

In 2005, Ukraine signed the European Declaration on Mental Health Protection and the European Action Plan on Mental Health Protection at the WHO European Conference “Mental Health Protection, Problems and Solutions”, which was held at the level of Ministers of Health in Helsinki, Finland.

Subsequently, the Concept of Development of Mental Health Care in Ukraine for the period until 2030 was developed, and approved by the Decree of the CMU dated 27 December 2017 No. 1018-r, and the Plan of Measures for its Implementation, approved by the Decree of the Cabinet of Ministers of Ukraine dated 06.10.2021 No. 1015.

According to these documents, priority tasks are the development and implementation of comprehensive, integrated, and effective mental health care systems that include elements such as health promotion, prevention, psychoeducation, treatment and rehabilitation, and health care and health restoration.

PURPOSE OF THE STUDY

The purpose of this study was to compare the latest data on the pathogenetic mechanisms, risk factors, and psychopathological consequences of the impact of the COVID-19 pandemic on the mental health of the population, on the basis of the scientific literature. The study was carried out within the scope of the scientific research work of the Department of General, Children’s Forensic Psychiatry, and Narcology of the Shupyk National Healthcare University of Ukraine. Its title was “Development of a multimodal system of restorative therapy and medical and psychological rehabilitation of patients with COVID-19, based on the study of leading pathogenetic mechanisms” (state registration number 0121U114707).

The electronic resource PubMed of the US National Center for Biotechnology Information (NCBI), the Internet data analysis system MEDLINE of the US National Library of Medicine (NLM), the National Scientific Medical Library of Ukraine (NSLMU), the Vernadsky National Library of Ukraine (NLU) and the sources in the databases Scopus and Web of Science were used for the analysis. This article considered scientific papers published in 2019-2021, as well as some papers published earlier if the research results presented in them were relevant to the problem under consideration. Particular attention was paid to methodologically sound studies and meta-analyses, due to the high level of presented evidence and their informative value, but papers clarifying and supplementing the data from the meta-analyses were also reviewed. Articles were selected based on the following keywords: COVID-19 pandemic, mental disorders, psychopathology, pathogenesis, therapy, rehabilitation. As a result, 253 published papers were reviewed, of which 89 articles were used in this analysis.

VIEWS

General information about mental disorders resulting from the COVID-19 pandemic

The COVID-19 pandemic is increasingly viewed through the prism of serious global mental health issues [1]. Initially, all the resources of society were directed to overcoming the systemic medical – including organizational – consequences of the coronavirus infection. Later, the focus shifted to mental issues due to the association of COVID-19 with mental and neurological disorders [2, 3]. In this regard, 89% of the world’s countries have already reported their initiation of mental health and psychosocial support solutions in their national COVID-19 control plans [4]. In addition, the application of strategies for the containment of COVID-19 have had a significant social and economic impact on all aspects of people’s lives. An additional, significant psycho-traumatic stressor has been the so-called atypical manifestation of overcoming the pandemic, intensifying the existing emergency of the public health care system [5-7].

The mental epidemic associated with COVID-19 has been confirmed by scientific research [8]. Although its impact on broad segments of global society has been defined as reversible, there remain large contingents of people who will have long-term mental consequences stemming from COVID-19 and the need to restore levels of social functioning and quality of life. Such vulnerable categories include medical workers, children and adolescents, the elderly, patients with mental disorders, and patients who have suffered from COVID-19 [9, 10]. The proportion of the latter is 80.6% of the total number of patients with coronavirus infection worldwide, and 81.4% in Ukraine [11].

Neuropsychiatric consequences of the COVID-19 pandemic

Most studies on the neuropsychiatric consequences of COVID-19 are limited to their manifestations at the pre-hospital and hospital stages. The impact of SARS-CoV-2 on the CNS and mental health of patients remains unclear [12]. The direct effect of the virus (encephalitis), neuroinflammation (cytokine storm in the brain tissue), multiple organ dysfunction, and cerebrovascular changes are potential casual mechanisms for the emergence of neurological and psychiatric symptoms [13-17]. Individual cases of viral encephalitis, hypoxic encephalopathy [18], meningitis-encephalitis [19], infectious- toxic encephalopathy, acute cerebrovascular diseases [20], primary psychotic episode [21, 22], and disorders of consciousness [23-26] have been described. Several studies devoted to the prevalence of psychoneurological symptoms [27-30].

The structural and biological similarity of SARS-CoV-2 with other CoVs [31] contributed at the beginning of the pandemic to assumptions about similar effects to MERS and SARS on the human psyche. Previous studies have confirmed that the new coronavirus pandemic has seriously affected the mental health of many of those infected. Two meta-analyses (12 and 38 studies, 20,404 individuals) indicated depression (35%), anxiety symptoms (28%) [31, 32], and post-traumatic stress disorder (PTSD) (18%) in patients with COVID-19 [33].

Scientific research on the effects of COVID-19 is still in the early stages of development. There is still a scientific discussion ongoing about terminological definitions (“Post-COVID,” “Long-COVID,” “Persistent Post-COVID”, “Post- Acute COVID”) [34-37]. There are also contradictions in the qualification and classification of post-covid syndromes due to a wide range of clinical presentations (respiratory, neurological, gastrointestinal, dermatological, etc.), which are difficult to differentiate from other diseases. The same applies to neuropsychiatric symptoms in the form of anxiety, depression, PTSD, sleep disorders, and suicidal behavior, the potential causes of which can be both direct SARS-CoV-2 and psychosocial stress caused by the COVID-19 pandemic [2, 34, 38-40].

The analysis of nososyndromic entities showed that two categories of mental disorders were observed: neurotic and psychotic. At the neurotic level, acute stress reaction, adjunctive disorder and anxiety-phobic disorders were observed, while the psychotic level included delirium with exacerbations, delirium of various types and mild cognitive disorders. To a lesser extent, hallucinatory- paranoid disorders were also observed.

Factors and category of increased risk

During the pandemic and its related restrictions, the world experienced a deep economic crisis that affected all segments of the population with varying degrees of force. The COVID-19 pandemic suddenly burst the everyday lives of people in virtually all countries, breaking life stereotypes formed over many decades [53-57]. To date, it has been established that COVID-19 has a negative impact on the mental health of the population worldwide [41-44, 50]. Negative emotional and stressful factors include fears of coronavirus infection, fear of a possible risk of infection, the unpredictable course of the disease, the lack of unambiguously stable treatment methods, and general uncertainty in society. This causes negative psychological reactions such as distress and maladaptation [51, 52, 58, 59]. According to the results of a study conducted in China, which included 1,200 participants, 54% of them rated the impact of COVID-19 as moderate or severe, 29% reported moderate-to-severe anxiety, 17% reported moderate-to-severe depressive symptoms, and more than 75% were worried that their relatives might be infected [42, 60, 61]. Another survey involving 53,000 respondents showed that 35% of participants experienced psychological stress: 29% from mild to moderate, and 5% severe [62, 63]. The measures taken in connection with the pandemic (quarantine, distance learning in schools and higher education institutions, remote work, closure of secondary enterprises, and limited movement) have a negative impact on people’s ordinary lives. It is believed that these measures can be predictors of the development of psychological and mental symptoms [45-49, 57, 64, 65].

Health care systems globally, and in particular psychiatric services, were used to addressing other problems, having been formed at a different time and for other purposes, and so they proved to be unprepared for the large number of patients with coronavirus infection who required medical care. During the pandemic, specific mental disorders appeared, and the peculiarities of their pathogenesis, pathophysiology, and clinical dynamics require studying. It should be emphasized that in the case of a severe form of coronavirus disease, the stigmatization of society limits the availability of highly qualified medical care for patients with mental disorders [27, 51, 66, 67].

Analysis of various influencing factors and randomized reference population groups showed that certain categories of the population were most prone to mental disorders. These include medical workers, elderly people, teenagers, and people with previously diagnosed mental disorders [55, 69]. Medical workers who were on the front line, in close contact with infected patients, were also subjected to excessive workloads, therefore, physical exhaustion, fear, emotional disorders, and sleep disorders were more often registered among them [59, 60, 70]. The reasons for this situation were inadequate personal care, intra-hospital transmission of infection, and ethically difficult decisions regarding medical triage when the medical system could not withstand the load [71, 72]. According to the data in one study [67], the prevalence of anxiety among medical workers was 23.21%. The study used the Tsun Self-Assessment Anxiety Scale (SAS), the Generalized Anxiety Disorder (GAD) questionnaire, and other measures. The prevalence of depression in this category of the population was 22.8% (according to the Tsun Self-Assessment Depression Scale [SDS] and Patient Health Assessment [PHQ-9], etc.). The overall prevalence of sleep disorders was 32%.

In contemporary scientific literature, data on the group analysis of the prevalence of anxiety and depression by sex, degree of severity, and professional group are defined and presented in sufficient detail. Various studies [61, 63, 71, 73] have found higher indicators of affective symptoms in female than in male doctors and medical personnel more generally. It should be emphasized that mild symptoms of both depression and anxiety were found in the majority of medical professionals, while moderate and severe symptoms were less common among the participants in our study. The prevalence of anxiety and depression was higher among paramedics than among doctors. These data may be distorted because most of the medical staff are women, but also by the fact that they spend more time in the wards, have more contact with patients, and are responsible for taking biological material for the detection of the virus. Also, on average, medical personnel were in closer contact with patients compared to doctors and were more exposed to psychological injuries associated with the death of patients and their physical suffering [61, 63, 71, 73]. The analysis of the behavioral reactions of medical personnel has mainly focused on non-specific astheno-neurotic and similar burnout syndrome states.

According to the literature [66], patients with mental disorders had several specific areas of vulnerability during the pandemic. They were much more likely to suffer from a concomitant pathology, which was a risk factor for the severe course of coronavirus disease. Indeed, according to the data of international researchers and our observations, there were some pre-dispositional factors that increased the likelihood of developing mental disorders. The most important of them, in our point of view were the intercurrent chronic somatic diseases, organic brain compromise, chemical addiction, and aging reference groups.

Elderly patients were more susceptible to the effects of coronavirus infection. Mortality from COVID-19 increased with age, and in people older than 80 years it was 14.8%. Elderly people are more likely to experience loneliness, which can increase during a pandemic, and in patients with mental disorders it can lead to the exacerbation of pathology [55, 56, 67, 74].

Prevalence of mental disorders due to the COVID-19 pandemic in adults

A study of 7,348 patients with a positive test result for coronavirus (SARS-CoV-2) was conducted to evaluate the relationship between mental disorders and mortality among adults with COVID-19, of whom 75 (1%) had a history of schizophrenia spectrum disorder, 564 (7.7%) had affective pathology, and 360 (4.4%) had anxiety disorder. Moreover, because of a retrospective analysis, it was established that the risk of death in patients with a diagnosis of the schizophrenic spectrum is 2.7 times higher than that in the general population, and that the risk of death in patients with affective pathology and anxiety disorders was statistically insignificant. At the same time, schizophrenic spectrum disorders ranked second as a risk factor for death, after age, based on the strength of the relationship of all demographic and medical risk factors reviewed in this study [49, 67].

According to a recent meta-analysis, the overall prevalence of PTSD and psychological distress in the general population during the pandemic was 23.88% and 24.84%, respectively. These data indicate that the prevalence of PTSD and psychological stress is increasing among the population [75, 79]. According to a systematic review and meta-analysis that included 62 studies with 162,639 participants from 17 countries worldwide, the overall prevalence of anxiety was 33%, with considerable heterogeneity. Various psychometric methods were used in the studies: the Beck Anxiety Scale (BAI), Depression, Anxiety and Stress Scale (DASS-21), the Generalized Anxiety Disorder Questionnaire (GAD-2/GAD-7), the Hamilton Anxiety Assessment Scale (HAM-A), the Hospital Anxiety and Depression Scale (HADS), the Patient Health Rating Scale (PHQ-4/PHQ-9) and the Tsun Self- Rated Anxiety Scale. The prevalence of anxiety was higher among patients (56%) than among medical professionals (26%) or the general population (32%). Among the medical workers, the prevalence of anxiety ranged from 7% in Singapore to 57% in Italy. It was established that the highest prevalence of anxiety among the population was observed in Italy – 81% [43, 58].

Among patients with COVID-19 and comorbidities, the prevalence of anxiety was consistently high, ranging from 40% in patients with type 2 diabetes in India to 82% in those with Parkinson’s disease in Iran. The prevalence of anxiety was 47% in patients with COVID-19, 50% in cancer patients, and 58% in caregivers of patients with Parkinson’s disease. Studies have shown that the prevalence of moderate-to-severe anxiety among patients with psychiatric disorders is 24% [66, 52]. In addition, because of a meta-analysis of studies in which psychometric scales were used, the prevalence of depression was found to be 28%. At the same time, the prevalence of depression was higher among patients (55%) than among medical workers (26%) or the general population (27%). Among healthcare workers, the prevalence of depression ranges from 9% in Singapore to 51% in China. The highest prevalence of depression was observed in Italy (67%). Patients with psychiatric disorders reported a prevalence of moderate to severe depression in 22% of cases [62, 67, 80].

It was crucial to compare the data from Southeast Asian countries, where the spread of COVID began, with the countries of Europe and the USA. The comparison of the clinical phenomenology of mental disorders revealed that in Ukraine there was a predominance of triadic, anxiety-depressive, and anxiety-phobic symptoms, including paroxysmal manifestations, with corresponding vegetative support in the syndromic structure.

Meta-analyses also provide data on the prevalence of distress, stress, and sleep disorders, which are 35%, 40%, and 32%, respectively. The prevalence of PTSD was highest among patients with COVID-19 (93%), healthcare workers, and the general population (3%) [49, 69, 80, 81].

In addition, in five studies the general prevalence of mental disorders ranged from 14% to 72% in medical workers and from 40% to 54% in the general population. At the same time, the prevalence of mental symptoms was higher among patients with already-existing pathological conditions and among patients with recently laboratory- confirmed COVID-19 [67, 68, 82, 83].

Peculiarities of mental disorders due to the COVID-19 pandemic in children

It is noted in the literature that the impact of the COVID-19 pandemic on children and adolescents will have more long-term global negative consequences, owing to the greater impact on their social and emotional development than on the adult population [55, 74, 84]. It should be emphasized that children, adolescents with mental disorders, and their families belonged to vulnerable groups during the pandemic. In children and adolescents, there was, during the quarantine period, a decrease in physical activity, excessive use of the Internet and social networks, and access to harmful content due to a long stay at home, violations of the work and rest regime, and violations of the nutrition regime. At the same time, social services did not work at full capacity during the quarantine period, and children who live in dysfunctional families rarely report abuse or violence [44].

According to the literature, adolescents with mental disorders do not tolerate isolation well, and are also prone to the interruption of drug therapy. The prevalence of obsessive-compulsive disorder (OCD) in children and adolescents is estimated at 0.25-4%. Children with OCD are thought to have been greatly affected by the pandemic because the main theme of their obsessive thoughts and actions is often related to cleanliness, frequent hand washing, fear of contamination, and cleanliness is the main measure of protection against the spread of the infection of COVID-19 [73, 80]. The prevalence of PTSD in quarantined children is reported to be 30%.

The danger of sudden death due to COVID-19 is a risk factor for PTSD and also of long-term depressive response. There are also data in the literature that the prevalence of depressive symptoms in adolescents is 43%, 37% of adolescents experience anxiety and 31% are affected by anxiety and depressive symptoms. At the same time, the highest risk factor for the development of these symptoms is female gender [58, 68].

Use of psychoactive substances, non-chemical addictions and other behavioral deviations

An important aspect of the problem was prolonged isolation during the coronavirus pandemic, which provoked children, adolescents, and adults to use alcohol, psychoactive substances (surfactants) and sedatives. The consumption of alcohol and surfactants accounts for approximately 1.5% of the total burden of disease, and in some countries, this percentage can reach 5%.

Currently, sporadic evidence of increased alcohol consumption during the pandemic has emerged in scientific publications, but in Ukraine it is extremely difficult to determine this trend because of regional restrictions and bans on alcohol sales during the ongoing war with the Russian aggressor and the virtually uncontrolled use of home-grown alcohol sold on the black market.

In addition to alcohol addiction and addiction to surfactants, addictive behavior associated with the “infodemic” and Internet addiction appeared during the pandemic. Excessive engagement in video games disrupts circadian rhythms and leads to persistent sleep disturbance and general asthenia of the body, which can be a predictor of coronavirus infection. Therefore, social isolation, stress, anxiety, worry, excessive leisure time playing video games, and social networks lead to an increase in non-chemical addiction, which also causes emotional lability, irritability, aggression, and anxiety [46, 47, 50, 61].

Modern infectious pandemics are accompanied by noninfectious mental epidemics. Thus, during the H1N1 influenza pandemic in 2009, a simultaneous emotional pandemic was recorded and, for the first time, the concept of “emotional epidemiology” was introduced into the scientific lexicon [60]. During pandemics, fear and anxiety are an integral part of the human mental state [43, 51, 56, 73]. The direct and indirect effects of the coronavirus disease (COVID-19) pandemic on the psychological well-being and mental health of the population are yet to be studied, but we can already analyze its short-term effects today.

The Director General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus officially confirmed the existence of the “infodemic” and called for fighting against it, since having covered the whole world it significantly complicated the fight against the real problem of overcoming the COVID-19 pandemic [42, 84]. In fact, the COVID-19 pandemic is the first pandemic in the world history that unfolded in the presence of Facebook and other social networks, and was therefore accompanied by unprecedented panic, the consequences of which significantly worsened the consequences of COVID-19. Excessive fixation (more than three hours per day) on information and problems related to the COVID-19 pandemic was a leading factor in the development of PTSD, anxiety-phobic, depressive disorders, and insomnia [54, 73, 81]. Chinese researchers have evaluated the relationship between mental health problems and exposure to social media during the COVID-19 pandemic. An online survey of 4,872 people over the age of 18, from 31 provinces and autonomous regions, was used to conduct mental health assessment. The prevalence of depression, anxiety, and a combination of both was 48.3%. More than 80% of participants reported that they were often influenced by social media. Researchers therefore propose to fight the “infodemic” during emergency situations [27, 80]. In addition, quarantine and social isolation were some of the factors that led to psychiatric disorders associated with the COVID-19 pandemic. Most people had never encountered these problems in their lives since the new era of control of the spread of infectious diseases began only in 2002-2003 during the outbreak of the SARS coronavirus (severe acute respiratory syndrome, “atypical pneumonia”) [68]. The related problems of unorganized free time, sensory deprivation and space limitation, reduced motor activity and constant interaction within a limited circle of people caused an increase in family violence, and in the number of divorces as well as the number of people addicted to alcohol and psychoactive substances [59, 65, 73, 80, 86].

During pandemics, the number of crimes, aggressive and self-aggressive forms of behavior, addiction to alcohol, and drugs increase. An increase in domestic violence was noted during the COVID-19 pandemic. Since a quarantine was announced in France in March 2020, the number of recorded acts of domestic violence during the lockdown increased by 30% while in quarantined areas of China, the number of divorces increased by 30% [52, 64, 71, 76, 77]. The risk of death by suicide increased by 42% in people with a history of hospitalization for infectious diseases [73, 80]. A scientific analysis of suicide mortality in the case of COVID-19 has not yet been conducted but reports of suicides among patients and medical workers have already appeared on the Internet [42].

During the pandemic, all hospital residents experienced episodes of non-pathological or pathological anxiety. In a study conducted in the wards of the Zhejiang University Medical School Hospital for patients with COVID-19, it was found that 48% of patients experienced psychological stress (pathological anxiety) upon admission [42, 45, 58, 67, 88]. Patients with COVID-19 also experienced organic anxiety, especially at a late stage of disease development, when their lungs were affected (the main cause of both the severity of the condition and its fatal consequences), as was the cardiovascular system, the kidneys, and the central nervous system (78-88% of patients with severe forms of COVID-19) [53, 69, 70, 87, 89].

CONCLUSIONS

Based on the material presented, it seems possible to conclude that, until now, no comprehensive studies have been conducted dedicated to the evolution of the mental consequences of the COVID-19 pandemic. Questions remain unresolved regarding the clinical phenomenology of mental disorders, the characteristics of the emotional and cognitive spheres, personality responses, levels of social functioning, and quality of life in COVID-19 survivors. There is a need to create a model of hierarchical, structural-functional pathogenetic links of mental disorders, as well as a target-oriented system of restorative therapy and medical-psychological rehabilitation for patients who have suffered from COVID-19. To some extent, both adequate and inadequate measures have been taken in the health care systems globally, but this can only be assessed retrospectively based on longitudinal observation data.

Nevertheless, new theoretical scientific data can provide the basis for further development of a multimodal model of hierarchical structural-functional pathogenetic links of disturbances to the mental sphere, as well as a target-oriented system of restorative therapy and medical- psychological rehabilitation of patients who have suffered from COVID-19. This is particularly important for numerous populations with predisposing, compromising factors, particularly people who have been exposed to war stress and combat trauma, forced migrants, children, the elderly, and other groups.

The introduction of such a system will minimize the impact of the COVID-19 pandemic and significantly improve the social functioning and quality of life of numerous segments of the population.

Our work was carried out in the summer and autumn of 2022, when there were no publications in the scientific literature on the relationship between the impact on the psyche of the population undergoing COVID-19, while the ruthless and criminal military invasion of Ukrainian territories by Russian troops took place. A promising direction is the creation of a system of targeted medical, psychological, psychotherapeutic, and psychiatric care for war-stress patients, combatants, refugees and internally displaced persons, whose medical history has been aggravated by COVID-19, and others those who were not taken ill during the 2029-2022 pandemic. Such studies are currently underway, also by the authors of this paper, which suggests that we plan to expand this review with new data in future publications.

Conflict of interest

Absent.

Financial support

The research work “Development of a multimodal system of restorative therapy and medical and psychological rehabilitation of patients with COVID-19 based on the study of leading pathogenetic mechanisms” is funded by Ministry of Public Health of Ukraine.

References

1 

Substantial investment needed to avert mental health crisis. 14 May 2020. News release. Available at: https://www.who.int/news/item/14-05-2020-substantial-investment-needed-to-avert-mental-health-crisis.

2 

Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun 2020; 89: 531-542.

3 

Penninx BWJH, Benros ME, Klein RS, Vinkers CH. How COVID-19 shaped mental health: from infection to pandemic effects. Nat Med 2022; 28: 2027-2037. DOI: 10.1038/s41591-022-02028-2.

4 

The impact of COVID-19 on mental, neurological and substance use services. Results of a rapid assessment. Publication: 5 October 2020. Available at: https://www.who.int/publications/i/item/978924012455.

5 

Troyer E, Kohn J, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun 2020; 87: 34-39.

6 

Chung RYN, Anti LMM. Chinese sentiment during the 2019-nCoV outbreak. Lancet 2020; 395: 686-687.

7 

Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg 2020; 61: E304-E312. DOI: 10.15167/2421-4248/jpmh2020.61.3.1530.

8 

Hossain M, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res 2020; 9: 636. DOI: 10.12688/f1000research.24457.1.

9 

Dubey S, Biswas P, Ghoshc R, Chatterjee S, Dubey MJ, Chatterjee S, et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr 2020; 14: 779-788.

10 

Preti E, Mattei VD, Perego G, Ferrari F, Mazzetti M, Taranto P, et al. The psychological impact of epidemic and pandemic outbreaks on healthcare workers: rapid review of the evidence. Curr Psychiatry Rep 2020; 22: 43. DOI: 10.1007/s11920-020-01166-z.

11 

Indexes of the Ministry of Finance of Ukraine. The COVID-19 coronavirus: general statistics. Available at: https://index.minfin.com.ua/reference/coronavirus/.

12 

Szcześniak D, Gładka A, Misiak B, Cyran A, Rymaszewska J. The SARS-CoV-2 and mental health: from biological mechanisms to social consequences. Prog Neuropsychopharmacol Biol Psychiatry 2021; 104: 110046. DOI: 10.1016/j.pnpbp.2020.110046.

13 

Clark IA, Vissel B. The meteorology of cytokine storms, and the clinical usefulness of this knowledge. Semin Immunopathol 2017; 39: 505-516.

14 

Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.

15 

Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies. J Biol Regul Homeost Agents 2020; 34: 327-331.

16 

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46: 846-848.

17 

Debnath M, Berk M, Maes M. Changing dynamics of psychoneuroimmunology during the COVID-19 pandemic. Brain Behav Immun Health 2020; 5: 100096. DOI: 10.1016/j.bbih.2020.100096.

18 

Chen G, Wu D, Guo W. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020; 130: 2620-2629.

19 

Moriguchi T, Harii N, Goto J. A first case of meningitis/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis 2020; 94: 55-58.

20 

Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020; 87: 18-22.

21 

Correa-Palacio AF, Hernandez-Huerta D, G’omez-Arnau J, Loeck C, Caballero I. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report. Psychiatry Res 2020; 290: 113115. DOI: 10.1016/j.psychres.2020.113115.

22 

Chandra PS, Shiva L, Nagendrappa S, Ganjekar S, Thippeswamy H. COVID 19 related psychoses as an interface of fears, socio-cultural issues and vulnerability–case report of two women from India. Psychiatry Res 2020; 290: 113136. DOI: 10.1016/j.psychres.2020.113136.

23 

Chen N, Zhou M, Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-513.

24 

Huang Y, Yang R, Xu Y, Gong P. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv; 2020. DOI: 10.1101/2020.02.27.20029009.

25 

Qi D, Yan X, Tang X. Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: a retrospective, descriptive, multiple-center study. medRxiv; 2020. DOI: 10.1101/2020.03.01.20029397.

26 

Leung KSS, Ng TTL, Wu AKL. A territory-wide study of early COVID-19 outbreak in Hong Kong community: a clinical, epidemiological and phylogenomic investigation. medRxiv; 2020. DOI: 10.1101/2020.03.30.20045740.

27 

Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurol 2020; 77: 683-690.

28 

Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis 2020; 71: 889-890.

29 

Helms J, Kremer S, Merdji H. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382: 2268-2270.

30 

Nalleballe K, Reddy Onteddu S, Sharma R, Dandu V, Brown A, Jasti M. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun 2020; 88: 71-74.

31 

Yu F, Du L, Ojcius DM, Pan C, Jiang S. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect 2020; 22: 74-79.

32 

Kong X, Zheng K, Tang M. Prevalence and factors associated with depression and anxiety of hospitalized patients with COVID-19. medRxiv; 2020. DOI: 10.1101/2020.03.24.20043075

33 

Salehi M, Amanat M, Mohammadi M, Salmanian M, Rezaei N, Saghazadeh A, Garakani A. The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: a systematic-review and meta-analysis. J Affect Disord 2021; 282: 527-538.

34 

Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado M, Florencio L. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health 2021; 18: 2621. DOI: 10.3390/ijerph18052621.

35 

Mahase E. Covid-19: what do we know about “long covid”? BMJ 2020; 370: m2815. DOI: 10.1136/bmj.m2815.

36 

Nabavi N. Long covid: how to define it and how to manage it. BMJ 2020; 370: m3489. DOI: 10.1136/bmj.m3489.

37 

National Institute for Health and Care Excellence (NICE), Royal College of General Practitioners, Healthcare Improvement Scotland SIGN. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: Termedia Publishing House 2020; National Institute for Health and Care Excellence. Available at: www.nice.org.uk/guidance/ng188 [Accessed: 30.12.2020].

38 

Magnavita N, Soave PM, Ricciardi W, Antonelli M. Occupational stress and mental health among anesthetists during the COVID-19 pandemic. Int J Environ Res Public Health 2020; 17: 8245. DOI: 10.3390/ijerph17218245.

39 

Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res 2020; 288: 112954. DOI: 10.1016/j.psychres.2020.112954.

40 

Magnavita N, Di Prinzio RR, Chirico F, Sacco A, Quintavalle G. COVID-19 and staff mental health: is there an evidence? An Italian field study. Eur J Public Health 2020; 30: ckaa165.565. DOI: 10.1093/eurpub/ckaa165.565.

41 

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220-232.

42 

Tkachenko OV. Impact of the COVID-19 pandemic on mental health (literature review). Sci Pract J Med 2021; 29: 55-59.

43 

Chaban OS, Haustova OO. Mental health during the COVID-19 pandemic (features of psychological crisis, anxiety, fear and anxiety disorders). Neuro News 2020; 3: 26-36.

44 

Yuryeva L, Shusterman T. The COVID-19 pandemic: risks to psychological well-being and mental health. Ukrains’kyi Visnyk Psykhonevrolohii 2020; 28: 5-10.

45 

Lund-Sørensen H, Benros ME, Madsen T. A nationwide cohort study of the association between hospitalization with infection and risk of death by suicide. JAMA Psychiatry 2016; 73: 912-919.

46 

Chan AOM, Huak CY. Psychological impact of the 2003 severe acute respiratory syndrome outbreak on health care workers in a medium size regional general hospital in Singapore. Occup Med Oxf Engl 2004; 54: 190-196.

47 

Ying Y, Ruan L, Kong F, Zhu B, Ji Y, Lou Z. Mental health status among family members of health care workers in Ningbo, China during the coronavirus disease 2019 (COVID-19) outbreak: a cross-sectional study. BMC Psychiatry 2020; 20: 379. DOI: 10.1186/s12888-020-02784-w.

48 

Leahy RL. Coronavirus anxiety. How to handle fear while pursuing safety. Psychology Today 2020; 4: 355-360.

49 

Derek T. The coronavirus will be a catastrophe for the poor. Atlantic 2020. 2 April 2020 [Accessed: 20.03.2020].

50 

Voloshyn PV, Maruta NO, Linsky IV. Recommendations of the Association of Neurologists, Psychiatrists and Narcologists of Ukraine regarding. Provision of psychiatric care during the COVID-19 epidemic. Kharkiv; 2020. p. 9.

51 

Kolifarhood G, Aghaali M, Saadati HM, et al. Epidemiological and clinical aspects of COVID-19; a narrative review. Arch Acad Emerg Med 2020; 8: e41.

52 

Sun T, Guan J. Novel coronavirus and central nervous system. Eur J Neurol 2020; 27: e52. DOI: 10.1111/ene.14227.

53 

Aguilera J. Xenophobia ‘Is a pre-existing condition.’ How harmful stereotypes and racism are spreading around the coronavirus. Time; 2020.

54 

Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 epidemic in China: a web-based cross-sectional survey. Psychiatry Res 2020; 288: 112954. DOI: 10.1016/j.psychres.2020.112954.

55 

World Health Organization. Mental health and psychosocial considerations during the COVID-19 outbreak. 28 March 2020.

56 

Rubin GJ, Wessely S. The psychological effects of quarantining a city. BMJ 2020; 368: m313. DOI: 10.1136/bmj.m313.

57 

Brook SK, Webster RK, Smith LE. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020; 395: 912-920.

58 

Lee J. Mental health effects of school closures during COVID-19. Lancet Child Adolesc Health 2020; 4: 421. DOI: 10.1016/S2352-4642(20)30109-7.

59 

Li Z. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav Immun 2020; 88: 916-919.

60 

Asselman V, Thienemann F, Pepper DJ. Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS 2010; 24: 2871-2876.

61 

Coronavirus: Shoppers stock up on alcohol amid lockdown. BBC World.

62 

Ofri D. The emotional epidemiology of H1N1 influenza vaccination. N Engl J Med 2009; 361: 2594-2595.

63 

Kim SY, Yoo B, Lee H. Psychiatric findings in suspected and confirmed Middle East respiratory syndrome patients quarantined in hospital: a retrospective chart analysis. Psychiatry Investig 2018; 15: 355-360.

64 

Liu S, Yang L, Zhang C. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry 2020; 7: e17-e18.

65 

Sarchiapone M, Iosue M. COVID-19 pandemic: increased risk for mental health problems and suicidal behavior. EPA; 2020.

66 

Organic, mental disorders: diagnosis, rehabilitation and prevention: education. Manual. Yuryeva LM (ed.). Dnipro: New Ideology; 2019.

67 

Clinically relevant drug-drug interaction between AEDs and medications used in the treatment of COVID-19 patients. Russo E, Iannone L (eds.). Updated to March 25, 2020.

68 

Xu Z, Shi L, Wang Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420-422.

69 

Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz 2020; 45: 230-232.

70 

Zhu Z, Xu S, Wang H, Liu Z, Wu J, Li G, et al. COVID-19 in Wuhan: sociodemographic characteristics and hospital support measures associated with the immediate psychological impact on healthcare workers. EClinicalMedicine 2020; 24: 100443. DOI: 10.1016/j.eclinm.2020.100443.

71 

Mazza C, Ricci E, Biondi S. Nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: immediate psychological responses and associated factors. Int J Environ Res Public Health 2020; 17: 3165. DOI: 10.3390/ijerph17093165.

72 

Yoon MK, Kim SY, Ko HS, Lee MS. System effectiveness of detection, brief intervention and refer to treatment for the people with post-traumatic emotional distress by MERS: a case report of community-based proactive intervention in South Korea. Int J Ment Health Syst 2016; 10: 51. DOI: 10.1186/s13033-016-0083-5.

73 

Guan WJ, Ni ZY, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-1720.

74 

Japan’s drop in suicides may not hold as fallout from pandemic grows. The Japan Times; 2020.

75 

Mykhaylov BV, Chugunov VV, Kurylo VO, Sarzhevskyi SN. Post-traumatic stress disorders: study guide. Mikhailov BV (ed.). 2nd ed. Khmapo; 2014.

76 

Mykhaylov BV, Zinchenko OM, Fedak BS, Sarvir IM. Emergency medical and psychological assistance to persons with acute mental and behavioral disorders of psychogenic origin: methodical recommendations. Khmapo; 2014.

77 

Mishiev VD, Mykhaylov BV. Clinic, diagnosis and treatment of emotional stress disorders. Clinical guidelines. Kyiv: Professional editions; 2021.

78 

Chaban OS, Haustova OO, Omelyanovych VYu. On the approval and implementation of medical and technological documents on the standardization of medical care for post-traumatic stress disorder. Order of the Ministry of Health of Ukraine dated February 23, 2016, Vol. 121.

79 

Emergency care in psychiatry and narcology: monograph. Kyiv: 2019.

80 

Gao J. Mental health problems and social media exposure during COVID-19 outbreak. PLoS One 2020; 15: e0231924. DOI: 10.1371/journal.pone.0231924.

81 

Liang T. Handbook of COVID-19 Prevention and Treatment. The First Affiliated Hospital, Zhejiang University School of Medicine; 2020.

82 

World Health Organization. Mental health and psychosocial considerations during the COVID-19 outbreak. WHO; 2020.

83 

Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Arch Acad Emerg Med 2020; 8: e17.

84 

Foot P. The problem of abortion and the doctrine of the double effect. Oxford Review 1967; 5: 5-15.

85 

Mykhaylov BV, Fedak BS. Psychotherapy in somatic medicine: monograph. “Dot”; 2017.

86 

Lurie I, Yang YX, Haynes K. Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry 2015; 76: 1522-1528.

87 

Coronavirus Disease 2019 (COVID-19) in the U.S. Centers for Disease Control and Prevention. 24 April 2020. The Coronavirus Recession Will Be Unusually Difficult to Fight. The Atlantic. Archived from the original on 24 March 2020.

88 

Zarocostas J. How to fight an infodemic. Lancet 2020; 395: 676. DOI: 10.1016/S0140-6736(20)30461-X.

89 

Xiao H, Zhang Y, Kong D. Social capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China. Med Sci Monit 2020; 26: e923921. DOI: 10.12659/MSM.923921.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0). License allowing third parties to download and share its works but not commercially purposes or to create derivative works.
 
© 2024 Termedia Sp. z o.o.
Developed by Bentus.